Drug factory · FDA FEI 3008828051
Zhejiang Yongtai Pharmaceutical Co., Ltd.
No. 1, 8th Donghai Avenue, Taizhou Bay Economic and Technological Development Zone, Linhai, Taizhou, China
Problems found, fixed voluntarily at FDA's last inspection, Mar 14, 2025.
Voluntary Action Indicated: inspectors found problems, but not serious enough for FDA to take action. The company is expected to fix them.
2 drug inspections on record since 2019: 1 with no problems, 1 with problems fixed voluntarily, 0 with FDA action.
What it does, for whom
| Drug | Role | For | NDC |
|---|---|---|---|
| Doxycycline | Makes it, tests it, packages it and labels it | Zhejiang Yongtai Pharmaceutical Co., Ltd. | 69434-016, 69434-017 |
| Esomeprazole | Makes it, tests it, packages it and labels it | Zhejiang Yongtai Pharmaceutical Co., Ltd. | 69434-012, 69434-013 |
| Gabapentin | Makes it, tests it, packages it and labels it | ACI Healthcare USA, Inc., Zhejiang Yongtai Pharmaceutical Co., Ltd. | 71093-161, 71093-162, 71093-163 +3 |
| Metoprolol | Makes the active ingredient | Youngtech Pharmaceuticals, Inc. | 69445-004, 69445-005, 69445-006 |
| Rosuvastatin | Makes it, tests it, packages it and labels it | Zhejiang Yongtai Pharmaceutical Co., Ltd. | 69434-005, 69434-006, 69434-007 +1 |
FDA inspection history
| Ended | Result | Program | Problems noted |
|---|---|---|---|
| Mar 14, 2025 | Problems found, fixed voluntarily | Drug Quality Assurance | — |
| Mar 22, 2019 | No problems found | Drug Quality Assurance | — |
Registered with FDA for: analysis; label; manufacture; pack.